Law360, New York (December 12, 2011, 3:45 PM ET) -- The Federal Circuit on Monday vacated an injunction barring Mylan Pharmaceuticals Inc. from producing a generic version of oral antibiotic Doryx while Warner Chilcott LLC pursues a patent infringement suit over the company's abbreviated new drug application.
Warner Chilcott filed suit in May 2009, claiming Mylan's plans to market a generic Doryx in 150-milligram delayed-release tablets infringed its patent for the drug, which is used to treat acne. In September, U.S. District Judge William Martini granted Warner's request for a preliminary injunction, finding the Irish drug...
Fed. Circ. Nixes Injunction On Mylan's Generic Doryx
To view the full article, take a free trial now.
